Selected article for: "immune response and main effect"
Author: Aaron Miller; Mac Josh Reandelar; Kimberly Fasciglione; Violeta Roumenova; Yan Li; Gonzalo H Otazu
Title: Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study
  • Document date: 2020_3_28
    • ID: 35meen0h_24
    Snippet: The correlation between the beginning of universal BCG vaccination and the protection against COVID-19 suggests that BCG might confer long-lasting protection against the current strain of coronavirus. However, randomized controlled trials using BCG are required to determine how fast an immune response develops that protects against COVID-19. BCG is generally innocuous with the main side effect the development of inflammation at the site of inject.....
    Document: The correlation between the beginning of universal BCG vaccination and the protection against COVID-19 suggests that BCG might confer long-lasting protection against the current strain of coronavirus. However, randomized controlled trials using BCG are required to determine how fast an immune response develops that protects against COVID-19. BCG is generally innocuous with the main side effect the development of inflammation at the site of injection. However, BCG is contraindicated in immune compromised people as well as pregnant women 13 , so care should be taken when applying these possible intervention for COVID-19.

    Search related documents:
    Co phrase search for related documents
    • BCG vaccination and injection site: 1, 2, 3, 4, 5, 6, 7
    • BCG vaccination and main effect: 1, 2, 3
    • compromised people and immune compromised people: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • control trial and immune response: 1, 2, 3, 4, 5
    • control trial and long last: 1
    • control trial and main effect: 1
    • coronavirus current strain and current strain: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • current strain and immune response: 1
    • immune response and inflammation development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • immune response and injection site: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • immune response and long last: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • immune response and main effect: 1, 2, 3, 4, 5, 6, 7
    • immune response and possible intervention: 1, 2, 3
    • injection site and possible intervention: 1
    • long last and possible intervention: 1